The non-receptor tyrosine kinase c-Abl is found in both the cytoplasm and the nucleus (Wang, 1993) . In addition to its kinase domain, c-Abl contains an SH2 domain, an SH3 domain, a nuclear localization sequence, and binding sites for DNA, the retinoblastoma protein and actin (Wang, 1993) . In the nucleus it is involved in cellular responses to DNA damage and regulation of cell cycle progression and apoptosis (Yuan et al., 1996; Gong et al., 1999; Agami et al., 1999) . Both the partitioning of c-Abl between nuclear and cytoplasmic compartments and c-Abl kinase activity were recently shown to be regulated by integrin-mediated cell adhesion (Lewis et al., 1996) . Adhesion of cells to the extracellular matrix (ECM) protein ®bronectin (FN) triggers a transient exit of cAbl from the nucleus, localization to focal adhesions and increased kinase activity, followed by return of the activated kinase to the nucleus at later times. Thus cAbl is a potential mediator of integrin signaling in the cytoplasm and nucleus.
c-Abl is the proto-oncogene for both v-Abl, the transforming gene of the Abelson feline leukemia virus and for Bcr-Abl, the oncogene responsible for human chronic myeloid leukemia (Wang, 1993) . Bcr-Abl is the product of the Philadelphia chromosome, a translocation that fuses the Bcr protein to a site near the Nterminus of c-Abl. The resultant gene product transforms hematopoietic cells and ®broblasts, and is found in 90% of chronic myeloid leukemias and 5 ± 10% of acute myeloid leukemias. Oncogenic variants of c-Abl are exclusively extranuclear, v-Abl being found mainly in the plasma membrane and Bcr-Abl being found in the cytoplasm and on actin ®laments.
Nuclear c-Abl is involved in cellular responses to DNA damage. It is activated when cells are irradiated or treated with DNA damaging chemicals, and contributes to cell cycle arrest and apoptosis via pathways involving p53, p73, ATM and the retinoblastoma protein (Gong et al., 1999; Agami et al., 1999; Baskaran et al., 1997; Welch and Wang, 1995; Kharbanda et al., 1995; Koleske et al., 1998) . By contrast, a function for cytoplasmic c-Abl has not been identi®ed. However, data from mice in which both cAbl and its homolog Arg (Abl-related gene) were deleted by homologous recombination indicate that these proteins have an essential role in the cytoplasm, possibly regulating cytoskeletal organization and cell polarity (Koleske et al., 1998) .
Oncogenes often behave as activated homologs of the normal cellular gene products, thus, additional clues concerning c-Abl cytoplasmic functions might be obtained from its oncogenic variants that are exclusively cytoplasmic. One pathway shared by both v-Abl and Bcr ± Abl is activation of the Ras pathway (Renshaw et al., 1996a,b; Goga et al., 1995; Rael et al., 1996) . Both were reported to interact with adapter molecules and to induce constitutive activation of Ras.
Plating of cells on FN or other ECM proteins triggers a transient induction of the classical MAP kinase (Erk) pathway (Chen et al., 1994; Renshaw et al., 1996a,b; Schlaepfer et al., 1994) . In 3T3 cells, this activation is maximal at 10 ± 30 min and then declines at later times. It is mediated by integrins, which can act via a number of pathways. For example, one pathway depends on focal adhesion kinase (FAK) (Schlaepfer et al., 1994) while a distinct pathway is dependent on the adapter protein Shc and the src family tyrosine fyn (Wary et al., 1996 (Wary et al., , 1998 . Integrin activation of the cAbl tyrosine kinase and targeting to focal adhesions (in cells plated on FN) occurs on a time scale similar to integrin activation of Erks (Lewis et al., 1996) . Together with the known activation of the MAP kinase pathway by oncogenic variants of Abl, this observation suggested that c-Abl might also contribute to the integrin activation of Erks.
To test possible involvement of c-Abl in integrin activation of MAP kinase, we ®rst examined whether cAbl can interact with upstream elements in the Ras/ MAP kinase pathway. Previous work demonstrated that plating cells on FN triggered c-Abl activation and focal adhesion localization that reached a maximum at 20 min after plating and subsequently declined (Lewis et al., 1996) . Therefore, NIH3T3 cells were detached from the substratum and plated on dishes coated with FN. When c-Abl was immunoprecipitated from cell lysate, Grb2 was found to co-precipitate maximally at 20 min after plating ( Figure 1a ) and to decrease at later times. A reciprocal immunoprecipitation with an antibody to Grb2 showed co-precipitation of c-Abl with similar adhesion dependence (Figure 1b ). Additional analyses failed to demonstrate any detectable association of c-Abl with focal adhesion kinase or p130 cas under identical conditions (not shown). These results indicate that c-Abl interacts with Grb2 in a speci®c and adhesion-dependent manner.
To test whether c-Abl might contribute to integrin activation of MAP kinase, we ®rst established a transient transfection Erk2 assay. NIH3T3 cells were transiently transfected with a low level (0.2 mg) of cDNA coding for HA-tagged Erk2. Cells were detached with trypsin-EDTA, maintained in suspension and then replated on plastic dishes coated with FN. Alternatively, cells were stimulated by addition of the phorbol ester TPA. The endogenous Erk2 or transfected HA-Erk2 was immunoprecipitated with antiErk2 or anti-HA from untransfected or transfected cells, respectively. Kinase activity assays showed very similar patterns of activity for the endogenous and transfected Erk2 under these conditions (Figure 2 ).
HA-Erk2 was then co-transfected with either WT cAbl or a kinase-defective c-Abl that functions as a dominant negative inhibitor. Empty vector was included in control transfections to keep total DNA constant. Plating cells on FN stimulated transient Erk2 activity in control cells (Figure 3a) . Erk2 activity was only slightly (*20%) higher in cells transfected with WT c-Abl, indicating that endogenous Abl levels are not strongly rate limiting. By contrast, the dominant negative c-Abl almost completely suppressed induction of Erk2 activity. To determine whether all non-receptor tyrosine kinases behave similarly, HA ± Erk2 was co-transfected with kinase-defective c-src (Kamps and Sefton, 1986) . This construct had no eect on adhesion-induced Erk2 activation. Western blots showed strong expression of Wt c-Abl, KD c-Abl and Kd c-src (Figure 3b ). To investigate whether the requirement for c-Abl was speci®c to the integrin-dependent activation of MAP kinase in cells on FN, adherent cells were stimulated with the phorbol ester TPA. The dominant negative c-Abl had no eect under these conditions (Figure 3c ). Additional experiments also showed no eect of dominant negative c-Abl on induction of MAP kinase activity by serum or PDGF (not shown). Thus, kinase-defective c-Abl functions as a highly speci®c inhibitor of the activation of Erk2 in cells replated on FN.
To test whether c-Abl is essential for FN activation of MAP kinase, a 3T3 cell line derived from Abl 7/7 mice was examined. These cells showed normal induction of ERK activity when plated on FN (not shown). Although these cells are likely to have adapted or compensated for the absence of c-Abl with time in culture, the data indicate that 3T3 cells must have additional, c-Abl-independent pathways that connect integrins to MAP kinase.
Previous papers have shown that, depending upon the biological context, both focal adhesion kinase and the adapter protein Shc can mediate integrin activation of Erk2 (Schlaepfer et al., 1994; Wary et al., 1996; Schlaepfer and Hunter, 1997) . Both FAK and Shc bind Grb2 following stimulation of integrins to mediate Ras activation. These two pathways appear to operate independently of each other, presumably contributing to Erk activity under dierent experimental conditions. Neither one is essential, since both FAK7/7 cells and Shc7/7 cells show some stimulation of MAP kinase when replated on FN (Sieg et al., 1998; T. Pawson, personal communication) . Our data now de®ne a third pathway connecting integrins to Grb2 and MAP kinase. The detailed mechanism by which c-Abl binds Grb2 and activates Erk could be complex; a sequence in c-Abl has been reported to bind directly to Grb2 were used for immunoprecipitation. Immune complexes were separated by SDS ± PAGE and immunoblotted. Blots were developed with antibodies against either Grb2 (upper) or c-Abl (8E9; lower). (b) Antibodies speci®c for Grb2 were used for immunoprecipitation. Immune complexes were split in half, separated by SDS ± PAGE and immunoblotted. Blots were developed with antibodies against c-Abl (8E9; upper) or Grb2 (lower) to show equivalent precipitation of Grb2. Cells were detached with trypsin, stopped with soybean trypsin inhibitor and resuspended in DMEM containing 0.1% nuclease-and proteasefree BSA (`DB'). Cells were either allowed to attach in DB to plates coated with FN or maintained in suspension on BSAcoated plates at 378. They were then extracted with 0.5 ml buer containing 1% NP40, 50 mM Tris-HCl, pH 7.4, 10 mM NaF, 2 mM sodium vanadate, 1 mM PMSF, and 10 mg/ml each of aproptinin and leupeptin, and centrifuged for 30 min at 14 000 g 48C. Samples containing 400 mg of protein were precleared with 20 ml of 50% G-sepharose slurry (Pierce, Rockford, IL, USA). Supernatants were incubated with antibody for 1 h on ice, then 30 ml of protein G-agarose slurry was added and samples were rotated at 48C for 3 h. Beads were washed and solubilized in SDS sample buer. One half of each sample was treated with DTT and run on 7% SDS-polyacrylamide gels to visualize c-Abl, the other half kept without DTT and analysed on 12% gels to visualize Grb2 or other cellular proteins (Ren and Baltimore, 1994) , though indirect routes involving other adapters may also exist (Zhao and Calame, 1999) . Clearly further work will be required to elucidate the detailed mechanism and the precise contribution of each pathway in dierent cell types under dierent conditions.
The biological consequences of integrin-induced MAP kinase activation are not well understood. Integrins contribute to the sustained activation of Erks by growth factors (Renshaw et al., 1997; Lin et al., 1997; Miyamoto et al., 1996) , which is important for cell cycle progression. However, the activation of Erks when cells are replated on FN is highly transient and is therefore unlikely to promote progression through G1. Integrin activation of MAP kinase has also been implicated in cytoskeletal organization and cell migration (Anand-Apte et al., 1997; Klemke et al., 1997; Gu et al., 1999) . One substrate for Erks that can lead to motility and changes in actin organization is myosin light chain kinase (Klemke et al., 1997) . Additionally, recent work showed that both FAK and Shc could work through Erks to promote integrin-mediated cell migration and cytoskeletal organization (Gu et al., 1999) . A role for MAP kinase and c-Abl in integrin signaling is therefore consistent with the altered cell migration and cytoskeletal organization observed in cAbl-de®cient mice (Koleske et al., 1998) . 5 NIH3T3 cells were plated in 60 mM tissue culture dishes and transfected using LipofectAMINE (GIBCO ± BRL). Each dish received 0.2 mg of HA-Erk DNA in the CMV5 vector, 0.2 mg DNA for bgalactosidase to normalize transfection eciency, plus 1.6 mg DNA coding for empty pSLX vector. At 24 h after transfection, cells were switched to DMEM with 0.5% calf serum for an additional 24 h. When indicated, cells were detached and held in suspension for 2 h then replated on dishes coated with FN as described above. Cells were lysed in buer with 1% NP40, 0.25 M NaCl and inhibitors (Renshaw et al., 1997) ; endogenous Erk2 was immunoprecipitated using polyclonal anti-Erk2 (Santa Cruz Biotechnology, Santa Cruz CA, USA) or transfected HA-tagged Erk2 immunoprecipitation with 12CA5. One third of the precipitates was analysed for Erk2 protein by Western blotting with anti-Erk2 antibody. The remaining two-thirds was assayed for Erk2 activity using an in-gel kinase assay as described (Renshaw et al., 1997; Kamashita and Fujisawa 1989) . Bands were quanti®ed by scanning densitometry and Erk activity normalized for variations in protein to determine the speci®c activity against chicken Src. We thank Tony Truong for outstanding technical assistance. This work was supported by USPHS grants R29 CA74230 to JM Lewis, F32 GM18298 to MW Renshaw and P01 HL57900 to MA Schwartz.
